Blood Count Test Helps Predict Leukemia Treatment Outcomes
Conquest - Summer 2010
Using information from a common and simple complete blood count test may more accurately predict treatment outcomes in young leukemia patients.
This retrospective study illustrated that the minimal residual disease indicator and the absolute lymphocyte count together enable physicians to better predict which patients with acute lymphocytic leukemia will remain disease free and who will most likely relapse.
Not only do low lymphocyte counts predict poor outcome, but patients with high lymphocyte counts also have excellent outcomes, and clinicians may be able to reduce the amount of chemotherapy these patients receive.
“Our ultimate goal is to use these prognostic tools in the future to guide treatments for our patients,” says Patrick Zweidler-McKay, M.D., Ph.D., assistant professor at MD Anderson’s Children’s Cancer Hospital and first author. “If we know that a patient is at high risk for relapse from the beginning, then potentially we can adjust the treatment plan to a more aggressive therapy.”
Reported in April at the annual meeting of the American Society of Pediatric Hematology/Oncology.
- Childhood leukemia
- News release
Conquest - Summer 2010
- Survivorship: the Next Step
- Radiological Physics Center Ensures Strength, Applicability of Clinical Trial Results
- It's All Happening in the Children's Cancer Hospital
- Nurturing Future Cancer Prevention Leaders
- Volunteer Pilots Help Connect Patients With Treatment
- Cancer Survivors' Stories: Reasons to Give
- Baseline PET Scans Becoming More Routine
- Moving Forward: Lisa Richardson
- Signs of Hope: 'Beads of Courage' Helps Children Cope With Cancer Treatment
- Chemo Combo Shows Promise for Endometrial Cancer Patients
- The Battle Against Lung Cancer Is On
- Chemoprevention for Colon Cancer
- Busulfan Improves Outcomes for Stem Cell Transplant Patients
- Bladder Cancer Risk Higher for Those Who Eat Well-Done Meat
- Stress Helps Ovarian Cancer Cells Escape
- Blood Count Test Helps Predict Leukemia Treatment Outcomes
- Genes Help Identify Some Glioblastomas
- Tool Measures Severity of Transplant-Related Symptoms
- New Guidance for Decisions on Preventive Breast Surgery
- Also in the News